Previous Close | 0.3500 |
Open | 0.2980 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's Range | 0.2980 - 0.3500 |
52 Week Range | 0.2980 - 2.6000 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
(Bloomberg) -- Rite Aid Corp.’s legal team sought to reassure creditors that the bankrupt pharmacy chain will survive Chapter 11, saying the company is still working with banks and a key bondholder group on a rescue deal that has taken longer than expected to finalize.Most Read from BloombergFed’s Favorite Underlying Inflation Gauge Is Seen CoolingIndia’s Markets Brace for Selloff as Modi’s Poll Goals in DoubtQatar Airways Jet Encounters Severe Turbulence, Leaving 12 HurtIsraeli Military Proceed
(Bloomberg) -- Some Rite Aid Corp. creditors have asked advisers representing the bankrupt pharmacy chain to cut their professional fees amid mounting liquidity concerns, according to people with knowledge of the situation. Most Read from BloombergThese Flight Routes Suffer the World’s Worst TurbulenceCiti Trader Got 711 Warning Messages Before Sparking Flash CrashNvidia Forecast Shatters Estimates as AI Boom Stays StrongOne Dead After Singapore Air Flight Hit By Severe TurbulenceThe drugstore c
Pharmacy chain Rite Aid has settled a critical dispute with drug supplier McKesson Corp to ensure that customers' prescriptions will continue to be filled during Rite Aid's bankruptcy, attorneys said on Tuesday. Rite Aid, which filed for Chapter 11 bankruptcy on Sunday night in New Jersey, sued McKesson the following morning, seeking to stop it from terminating a drug supply agreement that accounts for 98% of the pharmacy chain's prescription drug sales. Joshua Sussberg, an attorney for Rite Aid, announced the settlement at a Tuesday court hearing in Trenton, saying that McKesson would continue supplying drugs at least through the end of Rite Aid's bankruptcy case.